JMIR Publications has announced that JMIR Bioinformatics and Biotechnology has successfully passed the Scientific Quality Review conducted by the US National Library of Medicine (NLM) for inclusion in PubMed Central (PMC). This achievement underscores the journal's commitment to scientific excellence and editorial quality.
JMIR Bioinformatics and Biotechnology, launched in 2020, serves as a sister journal to the esteemed Journal of Medical Internet Research, renowned as the leading open-access journal in health informatics. With a focus on bioinformatics, genomics, and mathematical modeling in biology, JMIR Bioinformatics and Biotechnology provides a platform for cutting-edge research in these fields.
The acceptance of JMIR Bioinformatics and Biotechnology into PubMed Central (PMC) signifies a significant milestone for the journal. All articles published from 2022 onward will now be accessible on PMC and PubMed following their technical evaluation, enhancing the visibility and accessibility of the journal's scholarly content.
The inclusion of JMIR Bioinformatics and Biotechnology in PubMed Central (PMC) underscores its standing as a reputable source of scholarly research in the fields of bioinformatics, biotechnology, and mathematical modeling in biology. The journal remains committed to advancing knowledge and promoting scientific discourse in these critical areas of study.
Click here to read the original press release.
